Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Jolly Good Inc. Establishes North American Subsidiary: Joint Development of Medical VR for "Apple Vision Pro" with U.S. Experts 2023-11-01 21:00
I-Mab Announces Poster Presentations of 4-1BB Bispecific Antibody Portfolio at SITC 2023 2023-11-01 20:00
Curocell Completes Korea's First Phase 2 Clinical Trial for Next-Generation CAR-T 2023-11-01 16:23
Complete Genomics demonstrates technical and commercial momentum in the sequencing market through new customers, partnerships and collaborations less than one year after launching in the U.S. 2023-10-31 21:44
Lunit Joins as an Associate Partner with the World Economic Forum 2023-10-31 21:00
Meihua International Medical Technologies Co., Ltd. Establishes A Subsidiary Dedicated to Introducing International Patented Pharmaceuticals and Medical Device Technologies to China and Hainan Free Trade Port Boao Hope City 2023-10-31 20:00
CHIMERIC THERAPEUTICS ANNOUNCES FDA CLEARANCE OF IND APPLICATION FOR CHM 2101, A NOVEL CDH17 CAR T CELL THERAPY FOR ADVANCED GASTROINTESTINAL CANCERS 2023-10-31 19:00
TCI Unveils Revolutionary Weight Loss Formula at SupplySide West 2023 - Human Trials Showcase Remarkable Effectiveness in Just 14 Days! 2023-10-31 15:54
iNtRON, Executes Evaluation License and Option Agreement for SAL200 2023-10-31 12:20
Bridge Biotherapeutics Announces Initiation of Phase 1/2 Clinical Trial of BBT-207 in EGFR-Mutant NSCLC 2023-10-31 07:00
Pulsecare Medical's nsPFA clinical trial receives satisfactory short-term follow-up results 2023-10-30 23:02
AIRS Medical Accelerates Global Expansion, Showcasing clinical achievements of MRI Enhancement Solution at RSNA 2023 2023-10-30 23:00
WuXi AppTec Continued Solid Growth in the First Three Quarters of 2023 on Top of an Exceptionally Strong Year in 2022, with Profit Growth Continuously Exceeding Revenue Growth 2023-10-30 20:01
Journal of Thoracic Oncology Published Promising Results of Ivonescimab (PD-1/VEGF Bispecific) as First- or Second-line Therapy for Advanced or Metastatic Immunotherapy Naïve Non-Small-Cell Lung Cancer 2023-10-30 20:00
Foresee Pharmaceuticals to Present at the American Heart Association Annual Meeting Focusing on its ALDH2 activator FP-045 in Pulmonary Hypertension Associated with Interstitial Lung Disease 2023-10-30 15:18
Lunit Enters into Research Collaboration to Explore the Use of AI to Improve the Effectiveness of Immunotherapy 2023-10-27 21:07
Henlius Deepens Collaboration with Intas to bring Henlius' Novel anti-PD-1 mAb Serplulimab to Europe and India 2023-10-27 19:47
Meihua International Medical Technologies Co., Ltd.'s Subsidiary Officially Commences Construction of Comprehensive Medical Industrial Park in Hainan Free Trade Port Boao Hope City 2023-10-27 16:00
Chime Biologics and Hope Medicine Enter Manufacturing Agreement to Speed up the Launch of First-in-class Antibody Drug HMI-115 Targeting Endometriosis and Androgenic Alopecia 2023-10-26 22:49
Clarity and PSI kick off SAR-bisPSMA Phase III 2023-10-26 21:00
1 40 41 42 43 44 773